10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
9.40
+0.63 (7.13%)
May 12, 2025, 2:24 PM - Market open
10x Genomics Analyst Ratings
Total Analysts
15
Consensus Rating
Buy
Price Target
$17.81
Upside
+89.57%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $7.5 → $6.5 | Strong Sell | Maintains | $7.5 → $6.5 | -30.81% | May 12, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $18 → $15 | Strong Buy | Maintains | $18 → $15 | +59.66% | May 12, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $12 → $9 | Hold | Maintains | $12 → $9 | -4.20% | May 9, 2025 |
| Barclays | Barclays | Buy Maintains $15 → $12 | Buy | Maintains | $15 → $12 | +27.73% | Apr 10, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $20 → $15 | Strong Buy | Maintains | $20 → $15 | +59.66% | Mar 4, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $28 → $26 | Buy | Maintains | $28 → $26 | +176.74% | Feb 14, 2025 |
| Barclays | Barclays | Buy Maintains $18 → $15 | Buy | Maintains | $18 → $15 | +59.66% | Feb 14, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | +91.59% | Feb 13, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $23 → $20 | Strong Buy | Maintains | $23 → $20 | +112.88% | Feb 13, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $14 → $12 | Hold | Maintains | $14 → $12 | +27.73% | Feb 13, 2025 |
| UBS | UBS | Hold Maintains $20 → $14 | Hold | Maintains | $20 → $14 | +49.02% | Feb 13, 2025 |
| Stifel | Stifel | Strong Buy Maintains $21 → $18 | Strong Buy | Maintains | $21 → $18 | +91.59% | Feb 13, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $25 → $12 | Buy → Hold | Downgrades | $25 → $12 | +27.73% | Feb 13, 2025 |
| Barclays | Barclays | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +91.59% | Feb 10, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $30 → $28 | Buy | Maintains | $30 → $28 | +198.03% | Jan 13, 2025 |
| Barclays | Barclays | Buy Maintains $21 → $19 | Buy | Maintains | $21 → $19 | +102.24% | Nov 1, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.